METHODS: A total of 36 adult zebrafish were divided into two groups: control (n = 17) and rotenone-treated (n = 19). Fish were treated with rotenone water (5 µg/L water) for 28 days and subjected to locomotor behavior analysis. Total RNA was extracted from the brain tissue after rotenone treatment. The cDNA synthesized was subjected to microarray analysis and subsequently validated by qPCR.
RESULTS: Administration of rotenone has significantly reduced locomotor activity in zebrafish (p < 0.05), dysregulated dopamine-related gene expression (dat, th1, and th2, p < 0.001), and reduced dopamine level in the brain (p < 0.001). In the rotenone-treated group, genes involved in cytotoxic T lymphocytes (gzm3, cd8a, p < 0.001) and T cell receptor signaling (themis, lck, p < 0.001) were upregulated significantly. Additionally, gene expression involved in microgliosis regulation (tyrobp, p < 0.001), cellular response to IL-1 (ccl34b4, il2rb, p < 0.05), and regulation of apoptotic process (dedd1, p < 0.001) were also upregulated significantly.
CONCLUSION: The mechanisms of T cell receptor signaling, microgliosis regulation, cellular response to IL-1, and apoptotic signaling pathways have potentially contributed to PD development in rotenone-treated zebrafish.
OBJECTIVE: To develop and validate a bilingual questionnaire (MyACE) assessing perceived usefulness (PU), perceived ease of use (PEOU), satisfaction, and functionality of MyUBAT among adult users.
METHODS: This cross-sectional study developed a questionnaire integrating constructs from Technology Acceptance Model, Mobile App Rating Scale and System Usability Scale. Two rounds of content validation involving eight experts were conducted using the Item-level Content Validity Index (I-CVI). The bilingual (English and Malay) version underwent face validation with 10 adults from the general public via the Item-level Face Validity Index (I-FVI). A pilot study recruited end-users (N = 30) via convenience sampling at outpatient pharmacy units to evaluate internal consistency using Cronbach's alpha and Corrected Item-Total Correlation (CITC).
KEY FINDINGS: MyACE (20 items) showed strong content validity (I-CVI: 0.88-1.00; S-CVI/Ave: 0.96) and excellent face validity (I-FVI ≥ 0.83 for 19/20 items; S-FVI/Ave: 0.99; S-FVI/UA: 0.90). Pilot testing confirmed excellent overall reliability (α = 0.91), with strong domain-specific reliability for Functionality (α = 0.90) and Satisfaction (α = 0.80). Although PU (α = 0.55) and PEOU (α = 0.62) showed lower reliability, all items were retained after considering overall reliability and CITC results.
CONCLUSION: The MyACE questionnaire demonstrated good validity and excellent reliability, supporting its use as a bilingual instrument to evaluate user perceptions of the MyUBAT mobile application and providing a foundation for future large-scale validation.